Individualized Hemodynamic Management in Newborns
In our aim to improve patient outcome we are transitioning from a “one-size-fits-all” protocolized approach toward an individualized hemodynamic management, that is tailored to the cardiovascular (patho-)physiology and the specific clinical characteristics of each individual patient. In this narrati...
Main Author: | Willem P. de Boode |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.580470/full |
Similar Items
-
Size of Patent Ductus Arteriosus and Echocardiographic Markers of Shunt Volume in Preterm Infants Based on Postnatal Age
by: Eui Kyung Choi, et al.
Published: (2021-04-01) -
Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
by: Wei Qi, et al.
Published: (2012-10-01) -
Commonly used medications for respiratory and cardiovascular support in neonates: Evidence, knowledge gaps, and future perspectives
by: Eleni Agakidou, et al.
Published: (2024-09-01) -
Hemodynamic factors analysis on patent ductus arteriosus (PDA) closure devices /
by: Munder Mustaq Mohammed Azhar, 1994-, author, et al.
Published: (2018) -
Hemodynamic factors analysis on patent ductus arteriosus (PDA) closure devices /
by: Munder Mustaq Mohammed Azhar, 1994-, author, et al.
Published: (2018)